BCYC - Bicycle Therapeutics GAAP EPS of -$0.62 beats by $0.66 revenue of $19.53M beats by $13.5M
2024-05-02 07:56:32 ET
More on Bicycle Therapeutics
- Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point
- Cantor sees strong year ahead for oncology M&A
- Bicycle Therapeutics gains as former Seagen holder boosts stake
- Seeking Alpha’s Quant Rating on Bicycle Therapeutics
- Historical earnings data for Bicycle Therapeutics